Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ring chromosome 17 syndrome is a rare chromosomal anomaly syndrome, resulting from partial deletion of chromosome 17, characterized by highly variable manifestations, ranging from a severe phenotype which presents with lissencephaly and severe intellectual disability to a milder phenotype that includes short stature, microcephaly, intellectual disability, seizures (that may be pharmacoresistant), café-au-lait spots, retinal flecks and minor facial dysmorphism, depending on the presence or absence of the Miller-Dieker critical region.
Features include common findings: Cafe-au-lait spot, Intellectual disability, Seizure, and Global developmental delay and others; and sometimes findings: Microcephaly, Epicanthus, Micrognathia, and Wide nasal bridge and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Intellectual disability, Seizure, Global developmental delay |
Biomarker and diagnostic research for ring chromosome 17 has been reported in the published literature.
Phenotype severity distribution: 6 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ring chromosome 17.
105 publications have been identified in PubMed for ring chromosome 17. Research spans Basic Science / Preclinical (76%), Review / Meta-Analysis (8%), and Gene Therapy / Novel Therapeutics (6%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 78 | 76% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 7:28 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Growth and development |
3 |
Short stature, Growth delay, Intrauterine growth retardation |
Eyes | 1 | Retinal flecks |
Head and neck | 1 | Microcephaly |
Muscles | 1 | Low muscle tone (hypotonia) |
Arms and legs | 1 | Toe syndactyly |
8 |
8% |
New treatment approaches | 6 | 6% |
Patient case studies | 4 | 4% |
Other research | 2 | 2% |
Testing and diagnosis research | 2 | 2% |
Clinical study results | 2 | 2% |
Disease patterns and progression | 1 | 1% |
SanInocencio C (2026). [PMID: 41533279](https://pubmed.ncbi.nlm.nih.gov/41533279/). *Qual Life Res*. [Other]
Qian W (2026). [PMID: 41806826](https://pubmed.ncbi.nlm.nih.gov/41806826/). *Journal of the American Chemical Society*. [Basic Science / Preclinical]
Malik AQ (2026). [PMID: 41977415](https://pubmed.ncbi.nlm.nih.gov/41977415/). *Int J Mol Sci*. [Basic Science / Preclinical]
Becker F (2026). [PMID: 41543169](https://pubmed.ncbi.nlm.nih.gov/41543169/). *Nucleic acids research*. [Gene Therapy / Novel Therapeutics]
Diers A (2026). [PMID: 42171256](https://pubmed.ncbi.nlm.nih.gov/42171256/). *Food Funct*. [Basic Science / Preclinical]
Droß F (2026). [PMID: 41505093](https://pubmed.ncbi.nlm.nih.gov/41505093/). *Nucleic acids research*. [Basic Science / Preclinical]
Vogel CD (2026). [PMID: 41594113](https://pubmed.ncbi.nlm.nih.gov/41594113/). *Antibiotics (Basel, Switzerland)*. [Basic Science / Preclinical]
Stefanyshena N (2026). [PMID: 41574433](https://pubmed.ncbi.nlm.nih.gov/41574433/). *Nucleic acids research*. [Basic Science / Preclinical]
Chong ML (2026). [PMID: 42206203](https://pubmed.ncbi.nlm.nih.gov/42206203/). *Genet Med Open*. [Basic Science / Preclinical]
Grandhi GK (2026). [PMID: 41234677](https://pubmed.ncbi.nlm.nih.gov/41234677/). *Journal of materials chemistry. A*. [Review / Meta-Analysis]